The Relationship Between SHBG, Free Testosterone, and Pituitary Response

How SHBG Affects Testosterone Availability

• SHBG binds testosterone with high affinity, reducing the amount of free testosterone available for biological activity 1
• When SHBG levels increase, a greater proportion of total testosterone becomes bound, decreasing the free and bioavailable testosterone fractions 1

Pituitary Response to Reduced Free Testosterone

• The pituitary gland primarily senses free testosterone levels rather than total testosterone when regulating the hypothalamic-pituitary-gonadal axis 1
• This reduced negative feedback can lead to increased secretion of gonadotropins (FSH and LH) to stimulate more testosterone production 1

Evidence from Clinical Studies

• In men with elevated SHBG, the free testosterone index (total testosterone/SHBG ratio) decreases, which can trigger compensatory mechanisms 1

Clinical Implications

• When evaluating hypogonadism, both total and free testosterone should be measured, especially when SHBG levels may be abnormal 1
• A free testosterone index (total testosterone/SHBG ratio) <0.3 indicates hypogonadism and may reflect the body's attempt to compensate through increased gonadotropin secretion 1
• Conditions that increase SHBG (aging, hyperthyroidism, liver disease, certain medications) may lead to symptoms of testosterone deficiency despite normal total testosterone levels 2, 1

Factors That Affect SHBG Levels

• SHBG increases with: aging, hyperthyroidism, hepatic disease, certain medications (anticonvulsants, estrogens, thyroid hormone), smoking, and HIV/AIDS 2, 1
• SHBG decreases with: obesity, insulin resistance, hypothyroidism, certain medications (glucocorticoids, testosterone, anabolic steroids), acromegaly, and Cushing's disease 2, 1

Clinical Pitfalls to Avoid

• Relying solely on total testosterone measurements can miss cases of functional hypogonadism caused by elevated SHBG 1
• Not considering the impact of medications and medical conditions on SHBG levels can lead to incorrect interpretation of testosterone test results 2, 1

Relationship Between High SHBG and FSH Levels

Clinical Evidence

• In patients with functional hypothalamic amenorrhea (FHA) without polycystic ovarian morphology (PCOM), higher SHBG levels are associated with higher FSH levels compared to those with FHA-PCOM 3, 4, 5
• The Endocrine Society suggests that higher SHBG levels in FHA patients are linked to higher FSH levels, while lower SHBG levels are associated with lower FSH levels 3, 6
• In chronic liver disease, elevated SHBG levels due to liver dysfunction can affect the hypothalamic-pituitary axis, leading to altered gonadotropin levels 7, 8
• The American Association for the Study of Liver Diseases notes that chronic liver disease can disrupt the hypothalamic-pituitary axis, resulting in altered gonadotropin levels, including FSH 7, 9

Clinical Conditions

• Functional Hypothalamic Amenorrhea (FHA): Patients with higher SHBG levels show higher FSH levels, according to the American College of Obstetricians and Gynecologists 3, 6
• Chronic Liver Disease: Elevated SHBG levels can affect the hypothalamic-pituitary axis, leading to altered gonadotropin levels, as stated by the European Association for the Study of the Liver 7, 9

Management of Very High SHBG

Causes and Diagnosis

• The European Urology guidelines suggest that very high SHBG is typically caused by acquired conditions, such as hyperthyroidism, hepatic disease, aging, certain medications, smoking, and HIV/AIDS, rather than primary genetic disorders 10
• Identifying and treating the underlying condition causing elevated SHBG is the most effective approach to lowering SHBG, according to the European Urology guidelines 10

Lifestyle Modifications

• The European Urology guidelines recommend evaluating liver function tests, as hepatic disease can elevate SHBG 10
• Consider HIV testing in appropriate clinical contexts, as HIV/AIDS is associated with elevated SHBG, as suggested by the European Urology guidelines 10

Pharmacological Approaches

• Medications that decrease SHBG include growth hormone, glucocorticoids, and testosterone or anabolic androgenic steroids, however, these should only be used when clinically indicated for other conditions, not solely to lower SHBG, as stated in the European Urology guidelines 10

Management of Elevated SHBG in Males

Diagnostic Approach and Treatment

• The American Diabetes Association, as reported in Diabetes Care, recommends measuring morning total testosterone using an accurate assay in patients with decreased libido, erectile dysfunction, reduced muscle mass, or fatigue 11
• The American College of Physicians, as reported in the New England Journal of Medicine, suggests correcting hyperthyroidism if present, and managing liver disease appropriately to treat the underlying condition of elevated SHBG 12
• Testosterone replacement may be appropriate in symptomatic men with documented low free testosterone, even if total testosterone is normal, according to Diabetes Care, with benefits including improved sexual function, well-being, muscle mass, and bone density 11
• The New England Journal of Medicine recommends monitoring patients on testosterone replacement therapy carefully, including performing baseline digital rectal exam and PSA, then following PSA every 3-6 months in the first year, and checking hematocrit/hemoglobin regularly 12

Monitoring and Follow-up

• The New England Journal of Medicine suggests monitoring patients on testosterone replacement therapy every 3-6 months for the first year, then annually, with assessments including urinary symptoms, sleep apnea exacerbation, gynecomastia, digital rectal examination, and checks of testosterone, hematocrit/hemoglobin, and PSA 12
• Consider prostate biopsy if PSA rises >1.0 ng/mL in any year, as recommended by the New England Journal of Medicine 12

Sex Hormone-Binding Globulin and Its Clinical Significance

Measurement and Interpretation

• The Endocrine Society recommends measuring morning total testosterone along with either free testosterone or calculating the free androgen index to accurately assess androgen status 13
• A free testosterone index less than 0.3 indicates hypogonadism, and both total and free testosterone should be measured when evaluating hypogonadism, especially when SHBG levels may be abnormal 13

Disease Association

• In patients with polycystic ovary syndrome (PCOS), low SHBG levels are a significant risk marker, and contribute to increased free testosterone, worsening hyperandrogenic symptoms 14

SHBG Testing in Men with Erectile Dysfunction

Primary Indications

• Testosterone should be measured in all men with organic erectile dysfunction, especially those who have failed phosphodiesterase‑5 inhibitor therapy, and SHBG should be measured concurrently to allow accurate interpretation of androgen status. 15

Guideline Recommendations

• The Princeton III Consensus and the British Society for Sexual Medicine recommend that both testosterone and SHBG be measured in every man evaluated for erectile dysfunction. 15

Diagnostic Implications of Elevated SHBG on Testosterone Assessment

Interpretation of Testosterone Measurements

• In individuals with an SHBG concentration around 74 nmol/L, total testosterone values may appear normal or even elevated, which can conceal underlying functional hypogonadism. 16
• The increase in SHBG markedly lowers free testosterone, so patients can exhibit androgen‑deficiency symptoms (e.g., reduced libido, fatigue) despite having normal total testosterone levels. 16

Recommended Testing Protocol

• Assess androgen status by obtaining a morning total testosterone sample (drawn between 8 AM and 10 AM) and measuring free testosterone using equilibrium dialysis; this combined approach reliably detects low bioavailable testosterone when SHBG is high. 16

Evaluation and Management of Low Libido Due to Elevated SHBG

Diagnostic Workup

• Morning total testosterone should be measured between 8:00 AM – 10:00 AM using a validated assay to establish baseline androgen status. The European Association of Urology recommends this timing for accurate assessment. 17
• Free testosterone must be quantified by equilibrium dialysis (gold‑standard) or estimated via the free androgen index (total testosterone ÷ SHBG). A free androgen index < 0.3 confirms functional hypogonadism even when total testosterone is within normal limits. 17
• LH and FSH measurements are required to differentiate primary from secondary hypogonadism after low free testosterone is identified. 17

Conditions That Elevate SHBG

• Hyperthyroidism (elevated TSH, free T4) is a recognized endocrine cause of increased SHBG. The European Association of Urology lists thyroid over‑activity among the key contributors. 18
• Physiologic aging is associated with a gradual rise in SHBG levels. 18
• Chronic liver disease (abnormal AST, ALT, alkaline phosphatase, bilirubin, albumin) markedly raises SHBG; cirrhosis is a classic example. 18
• Medications that raise SHBG include anticonvulsants such as phenytoin and carbamazepine, systemic estrogens (including oral contraceptives in transgender patients), and excessive thyroid hormone replacement. 18
• HIV/AIDS infection can increase SHBG; appropriate HIV testing is advised when clinically indicated. 18
• Current smoking is associated with higher SHBG concentrations. 18

Management Strategy

1. Treat the Underlying SHBG‑Elevating Condition First

• If hyperthyroidism is present, initiate antithyroid drugs, radioactive iodine, or surgery as per endocrine guidelines before considering androgen therapy. 18
• For hepatic disease, manage the liver pathology according to its etiology (e.g., antiviral therapy for viral hepatitis, lifestyle modification for fatty liver). 18
• When a medication is responsible, discontinue or substitute the offending agent if clinically feasible. 18
• In HIV‑related cases, optimize antiretroviral therapy to control viral load and improve SHBG levels. 18

2. Indications for Testosterone Replacement Therapy (TRT)

• Documented low free testosterone (or free androgen index < 0.3) together with persistent symptoms such as reduced libido, erectile dysfunction, decreased muscle mass, or fatigue. 17
• Failure to correct the underlying SHBG‑elevating factor after an appropriate trial of targeted therapy.

3. Expected Benefits of TRT

• Improvement in sexual function and libido in men with confirmed low free testosterone. 17
• Enhanced overall well‑being and mood reported after achieving therapeutic testosterone levels. 17
• Increase in muscle mass and strength, contributing to functional capacity. 17
• Positive effect on bone mineral density, reducing fracture risk. 17

4. Monitoring Requirements for TRT

• Baseline digital rectal examination and prostate‑specific antigen (PSA) testing before initiating therapy.
• PSA re‑assessment every 3–6 months during the first year, then annually to detect potential prostate pathology.
• Periodic hematocrit/hemoglobin checks to monitor for polycythemia.
• Evaluation for urinary symptoms, sleep‑apnea exacerbation, and gynecomastia at each follow‑up visit.
• Consider prostate biopsy if PSA rises > 1.0 ng/mL within any calendar year.

5. Fertility Considerations

• TRT suppresses the hypothalamic‑pituitary‑gonadal axis, potentially impairing spermatogenesis. Patients of reproductive age must be counseled about this risk before initiating therapy. 18

Clinical Pearls

• Never rely solely on total testosterone when SHBG abnormalities are suspected; free testosterone measurement is essential for accurate diagnosis of functional hypogonadism. 17
• The testosterone‑to‑SHBG ratio serves as a practical surrogate for free testosterone, aiding discrimination between true androgen deficiency and normal physiology. 17
• In obese individuals, SHBG is typically reduced; therefore, an elevated SHBG in this context suggests an alternative underlying cause such as thyroid disease or medication effect. 18